Dr. Kayvan Amjadi, University of Ottawa, Ottawa, ON
Many patients with benign pleural effusion suffer from disabling dyspnea and cough that severely impacts their quality of life. Vast majority of these patients suffer from impaired cardiac, renal, or hepatic function that is refractory to medical management, and they often have limited life expectancy. Management of their refractory pleural effusion often results in marked improvement in their dyspnea and quality of life. Although, chronic indwelling catheters are primarily promoted for outpatient management of patients with refractory malignant pleural effusion, more recently, these catheters have demonstrated similar beneficial outcomes in patients with benign disease. This presentation will review the literature supporting the use of chronic indwelling catheters in patients with benign, refractory, and symptomatic pleural effusion.
At the end of this presentation, attendees will be able to:
- review the literature for management of patients with pleural effusions secondary to advanced cardiac disease;
- review the literature for management of patients with pleural effusions related to renal insufficiency; and
- review the literature for management of patients with pleural effusions related to hepatic insufficiency.